Literature DB >> 16733419

3.0 Tesla contrast-enhanced MR angiography of carotid artery stents: in vitro measurements as compared with 1.5 Tesla.

S Hähnel1, T H Nguyen-Trong, S Rohde, M Hartmann, C Braun, K Sartor, S Heiland.   

Abstract

BACKGROUND AND
PURPOSE: To assess the appearance of carotid artery stents at 3.0 Tesla contrast enhanced magnetic resonance angiography (CE-MRA) as compared with 1.5 Tesla.
METHODS: 19 stents (GUIDANT Acculink, GUIDANT Dynalink, BOSTON SCIENTIFIC SMART Neuroform, GUIDANT Omnilink, EV3 Protege, BOSTON SCIENTIFIC Carotid Wallstent, ABBOTT Xact) of different materials (nitinol, stainless steal, cobalt alloy) and different sizes (4.0 mm-10.0 mm) were investigated regarding their appearance on CE-MRA at 3.0 Tesla and at 1.5 Tesla. For each stent artificial lumen narrowing (ALN) was calculated based on a pixel-by-pixel profile of the contrast-to-noise-ratio giving an objective indicator for the size of the evaluable stent diameter.
RESULTS: Only in two stents (Omnilink 7.0 mm, Omnilink 10.0 mm) was ALN higher at 3.0 Tesla relative to 1.5 Tesla. In all other stents ALN at 3.0 Tesla was the same or even lower as compared with 1.5 Tesla. In contrast to the ferromagnetic stents where ALN was typically higher than 85%, in most of the nitinol stents (Acculink, Dynalink, Neuroform, Protege) ALN was below 35%. In the Xact stents ALN was generally 100% at 1.5 Tesla and ranged between 31.8% and 100% at 3.0 Tesla.
CONCLUSION: CE-MRA after carotid artery stenting is considerably impaired by ALN both at 1.5 Tesla and at 3.0 Tesla. Nevertheless, CE-MRA is well suited for the examination of carotid artery stents made of nitinol at both field strengths. Stent manufacturers should be aware of potential artifacts caused by their stents during noninvasive diagnostic methods such as CE-MRA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16733419     DOI: 10.1016/s0150-9861(06)77234-0

Source DB:  PubMed          Journal:  J Neuroradiol        ISSN: 0150-9861            Impact factor:   3.447


  6 in total

1.  Comparing different MR angiography strategies of carotid stents in a vascular flow model: toward stent-specific recommendations in MR follow-up.

Authors:  Andreas M J Frölich; Sara M Pilgram-Pastor; Marios N Psychogios; Alexander Mohr; Michael Knauth
Journal:  Neuroradiology       Date:  2010-08-19       Impact factor: 2.804

2.  Carotid artery stents: in vitro comparison of different stent designs and sizes using CT angiography and contrast-enhanced MR angiography at 1.5T and 3T.

Authors:  M Lettau; A Sauer; S Heiland; S Rohde; M Bendszus; S Hähnel
Journal:  AJNR Am J Neuroradiol       Date:  2009-09-12       Impact factor: 3.825

3.  Contrast-Enhanced and Time-of-Flight MRA at 3T Compared with DSA for the Follow-Up of Intracranial Aneurysms Treated with the WEB Device.

Authors:  C Timsit; S Soize; A Benaissa; C Portefaix; J-Y Gauvrit; L Pierot
Journal:  AJNR Am J Neuroradiol       Date:  2016-04-21       Impact factor: 3.825

4.  Off-resonance magnetic resonance angiography improves visualization of in-stent lumen in peripheral nitinol stents compared to conventional T1-weighted acquisitions: an in vitro comparison study.

Authors:  Gitsios Gitsioudis; Philipp Fortner; Matthias Stuber; Anna Missiou; Florian Andre; Oliver J Müller; Hugo A Katus; Grigorios Korosoglou
Journal:  Int J Cardiovasc Imaging       Date:  2016-08-17       Impact factor: 2.357

5.  In vitro comparison of different carotid artery stents: a pixel-by-pixel analysis using CT angiography and contrast-enhanced MR angiography at 1.5 and 3 T.

Authors:  Michael Lettau; Annett Sauer; Sabine Heiland; Stefan Rohde; Julia Reinhardt; Martin Bendszus; Stefan Hähnel
Journal:  Neuroradiology       Date:  2009-11-19       Impact factor: 2.804

6.  Artificial luminal narrowing on contrast-enhanced magnetic resonance angiograms on an occasion of stent-assisted coiling of intracranial aneurysm: in vitro comparison using two different stents with variable imaging parameters.

Authors:  Jee Hyun Seok; Hyun Seok Choi; So-Lyung Jung; Kook-Jin Ahn; Myeong Jin Kim; Yong Sam Shin; Bum-soo Kim
Journal:  Korean J Radiol       Date:  2012-08-28       Impact factor: 3.500

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.